964 related articles for article (PubMed ID: 11212482)
1. Multidrug therapy--the pathway for global leprosy elimination.
al-Qubati Y; al-Kubati AS
Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
[TBL] [Abstract][Full Text] [Related]
2. [Eradication of leprosy and public health. Vaccination and multidrug therapy].
Janaszek W
Przegl Epidemiol; 2002; 56(4):577-86. PubMed ID: 12666583
[TBL] [Abstract][Full Text] [Related]
3. Global review of multidrug therapy (MDT) in leprosy.
Noordeen SK; Lopez Bravo L; Daumerie D
World Health Stat Q; 1991; 44(1):2-15. PubMed ID: 2068821
[TBL] [Abstract][Full Text] [Related]
4. Multidrug therapy (MDT) and leprosy control.
Noordeen SK
Indian J Lepr; 1990; 62(4):448-58. PubMed ID: 2086680
[No Abstract] [Full Text] [Related]
5. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010).
World Health Organization
Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281
[No Abstract] [Full Text] [Related]
6. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?
Richardus JH; Habbema JD
Lepr Rev; 2007 Dec; 78(4):330-7. PubMed ID: 18309706
[TBL] [Abstract][Full Text] [Related]
7. Elimination of leprosy as a public health problem: progress and prospects.
Noordeen SK
Bull World Health Organ; 1995; 73(1):1-6. PubMed ID: 7704919
[TBL] [Abstract][Full Text] [Related]
8. Are 18 doses of WHO/MDT sufficient for multibacillary leprosy; results of a trial in Malawi.
Pönnighaus JM; Boerrigter G
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):1-7. PubMed ID: 7730703
[TBL] [Abstract][Full Text] [Related]
9. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010.
WHO Regional Office for South-East Asia
Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282
[No Abstract] [Full Text] [Related]
10. Leprosy control through multidrug therapy (MDT).
Noordeen SK
Bull World Health Organ; 1991; 69(3):263-9. PubMed ID: 1893503
[TBL] [Abstract][Full Text] [Related]
11. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
12. Dapsone drug resistance in the MDT era.
Roche PW; Neupane KD; Failbus SS; Butlin CR
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
[No Abstract] [Full Text] [Related]
13. An 8-12 year follow-up of highly bacillated Indian leprosy patients treated with WHO multi-drug therapy.
Desikan KV; Sundaresh P; Tulasidas I; Rao PV
Lepr Rev; 2008 Sep; 79(3):303-10. PubMed ID: 19009979
[TBL] [Abstract][Full Text] [Related]
14. Primary dapsone resistance in Cebu, The Philippines; cause for concern.
dela Cruz E; Cellona RV; Balagon MV; Villahermosa LG; Fajardo TT; Abalos RM; Tan EV; Walsh GP
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):253-6. PubMed ID: 8862258
[TBL] [Abstract][Full Text] [Related]
15. A overview of ocular leprosy after 2 decades of multidrug therapy.
Lewallen S; Courtright P
Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278
[No Abstract] [Full Text] [Related]
16. Acceptance of WHO/MDT over the last 20 years.
Lechat MF
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):241-6. PubMed ID: 11875769
[No Abstract] [Full Text] [Related]
17. Multidrug therapy in leprosy.
Manglani PR; Arif MA
J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
[TBL] [Abstract][Full Text] [Related]
19. Leprosy in the WHO African region.
Daumerie D
World Health Stat Q; 1991; 44(1):16-22. PubMed ID: 2068820
[TBL] [Abstract][Full Text] [Related]
20. Leprosy at a turning point?
Harboe M
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
[No Abstract] [Full Text] [Related]
[Next] [New Search]
